Age <60 years, shorter ECMO duration and presence of infection are associated with in-hospital mortality https://t.co/n7bnC6xJ9w @SasaRajsic #VAECMO #Prognosis #Safety #AIC #FICS #SRLF https://t.co/KPWhcOUke4
RT @ecmologos: Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications https://t.co/dJEyZ…
RT @ecmologos: Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications https://t.co/dJEyZ…
Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications https://t.co/dJEyZXZKMc
RT @YukiKotani5: A recent meta-analysis of efficacy & complications in patients with carcinogenic shock receiving ECMO @of_aic
A recent meta-analysis of efficacy & complications in patients with carcinogenic shock receiving ECMO @of_aic
"Extracorporeal membrane oxygenation is an invasive life support with a high risk of complications. We identified a pooled in-hospital mortality of 62% with patient age, infection and ECMO support duration being associated with a higher mortality" https://
RT @YukiKotani5: ✅#ECMO for cardiogenic shock: a meta-analysis 📰32 studies with 12756 pts 🪦Hospital mortality: 62% (8493/12756, 32 studie…
RT @YukiKotani5: ✅#ECMO for cardiogenic shock: a meta-analysis 📰32 studies with 12756 pts 🪦Hospital mortality: 62% (8493/12756, 32 studie…
RT @YukiKotani5: ✅#ECMO for cardiogenic shock: a meta-analysis 📰32 studies with 12756 pts 🪦Hospital mortality: 62% (8493/12756, 32 studie…
RT @YukiKotani5: ✅#ECMO for cardiogenic shock: a meta-analysis 📰32 studies with 12756 pts 🪦Hospital mortality: 62% (8493/12756, 32 studie…
✅#ECMO for cardiogenic shock: a meta-analysis 📰32 studies with 12756 pts 🪦Hospital mortality: 62% (8493/12756, 32 studies) 🩸Bleeding: 48% (1971/4523, 15 studies) 🦠Sepsis: 18% 9 (489/2529, 9 studies) 🔗https://t.co/XEhrZWMP3O #FOAMcc #ELCS #Cardiotwitter